Using whole slides of non-cultured patient tumor tissue, our results supported this showing that TfR1, FTH, and FTL were co-expressed to some extent with the stem cell marker CD133, and we furthermore found that TfR1 was elevated in GBMs and associated with short survival in astrocytomas. The gene discussed is FTL; the disease is astrocytoma (excluding glioblastoma).